BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38798354)

  • 1. G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.
    Mazharian A; Bertin O; Sarkar A; Augros J; Bornert A; Loubière C; Jönsson F; Warwicker J; Abbott WM; Dushek O; Vayne C; Rauova L; Fütterer K; Rollin J; Poncz M; Senis YA
    bioRxiv; 2024 May; ():. PubMed ID: 38798354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.
    Geer MJ; van Geffen JP; Gopalasingam P; Vögtle T; Smith CW; Heising S; Kuijpers MJE; Tullemans BME; Jarvis GE; Eble JA; Jeeves M; Overduin M; Heemskerk JWM; Mazharian A; Senis YA
    Blood; 2018 Sep; 132(13):1413-1425. PubMed ID: 29891536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function.
    Mazharian A; Wang YJ; Mori J; Bem D; Finney B; Heising S; Gissen P; White JG; Berndt MC; Gardiner EE; Nieswandt B; Douglas MR; Campbell RD; Watson SP; Senis YA
    Sci Signal; 2012 Oct; 5(248):ra78. PubMed ID: 23112346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B-deficient mice.
    Mazharian A; Maître B; Bornert A; Hennequin D; Lourenco-Rodrigues M; Geer MJ; Smith CW; Heising S; Walter M; Montel F; Walker LSK; de la Salle H; Watson SP; Gachet C; Senis YA
    Blood Adv; 2023 Jan; 7(1):46-59. PubMed ID: 36269841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.
    Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP
    J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting platelet inhibition receptors for novel therapies: PECAM-1 and G6b-B.
    Soriano Jerez EM; Gibbins JM; Hughes CE
    Platelets; 2021 Aug; 32(6):761-769. PubMed ID: 33646086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.
    Vögtle T; Sharma S; Mori J; Nagy Z; Semeniak D; Scandola C; Geer MJ; Smith CW; Lane J; Pollack S; Lassila R; Jouppila A; Barr AJ; Ogg DJ; Howard TD; McMiken HJ; Warwicker J; Geh C; Rowlinson R; Abbott WM; Eckly A; Schulze H; Wright GJ; Mazharian A; Fütterer K; Rajesh S; Douglas MR; Senis YA
    Elife; 2019 Aug; 8():. PubMed ID: 31436532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITIM receptors: more than just inhibitors of platelet activation.
    Coxon CH; Geer MJ; Senis YA
    Blood; 2017 Jun; 129(26):3407-3418. PubMed ID: 28465343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.
    Gardiner EE; Karunakaran D; Arthur JF; Mu FT; Powell MS; Baker RI; Hogarth PM; Kahn ML; Andrews RK; Berndt MC
    Blood; 2008 Jan; 111(1):165-74. PubMed ID: 17848620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of hierachical protein recruitment to the inhibitory platelet receptor, G6B-b.
    Coxon CH; Sadler AJ; Huo J; Campbell RD
    PLoS One; 2012; 7(11):e49543. PubMed ID: 23185356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.
    Mori J; Nagy Z; Di Nunzio G; Smith CW; Geer MJ; Al Ghaithi R; van Geffen JP; Heising S; Boothman L; Tullemans BME; Correia JN; Tee L; Kuijpers MJE; Harrison P; Heemskerk JWM; Jarvis GE; Tarakhovsky A; Weiss A; Mazharian A; Senis YA
    Blood; 2018 Mar; 131(10):1122-1144. PubMed ID: 29301754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.
    Hofmann I; Geer MJ; Vögtle T; Crispin A; Campagna DR; Barr A; Calicchio ML; Heising S; van Geffen JP; Kuijpers MJE; Heemskerk JWM; Eble JA; Schmitz-Abe K; Obeng EA; Douglas M; Freson K; Pondarré C; Favier R; Jarvis GE; Markianos K; Turro E; Ouwehand WH; Mazharian A; Fleming MD; Senis YA
    Blood; 2018 Sep; 132(13):1399-1412. PubMed ID: 29898956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development.
    Lee RH; Bergmeier W
    J Thromb Haemost; 2016 Apr; 14(4):645-54. PubMed ID: 26749528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein.
    Senis YA; Tomlinson MG; García A; Dumon S; Heath VL; Herbert J; Cobbold SP; Spalton JC; Ayman S; Antrobus R; Zitzmann N; Bicknell R; Frampton J; Authi KS; Martin A; Wakelam MJ; Watson SP
    Mol Cell Proteomics; 2007 Mar; 6(3):548-64. PubMed ID: 17186946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPVI levels in platelets: relationship to platelet function at high shear.
    Best D; Senis YA; Jarvis GE; Eagleton HJ; Roberts DJ; Saito T; Jung SM; Moroi M; Harrison P; Green FR; Watson SP
    Blood; 2003 Oct; 102(8):2811-8. PubMed ID: 12829582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.
    Dütting S; Vögtle T; Morowski M; Schiessl S; Schäfer CM; Watson SK; Hughes CE; Ackermann JA; Radtke D; Hermanns HM; Watson SP; Nitschke L; Nieswandt B
    Circ Res; 2014 Jan; 114(3):444-453. PubMed ID: 24265393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
    Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
    Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo.
    Zhi H; Rauova L; Hayes V; Gao C; Boylan B; Newman DK; McKenzie SE; Cooley BC; Poncz M; Newman PJ
    Blood; 2013 Mar; 121(10):1858-67. PubMed ID: 23264598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets.
    Cicmil M; Thomas JM; Leduc M; Bon C; Gibbins JM
    Blood; 2002 Jan; 99(1):137-44. PubMed ID: 11756163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet glycoprotein VI: its structure and function.
    Moroi M; Jung SM
    Thromb Res; 2004; 114(4):221-33. PubMed ID: 15381385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.